The Donut Hole Dilemma: Retaining Lost Patients Under Medicare Part D
This article was originally published in RPM Report
Executive Summary
Finally, some statistics about the impact of the Medicare Part D donut hole. The good news: drug manufacturers need not worry about most patients entering the coverage gap. The bad: a relatively large number of the industry's best customers do reduce their medication use in the donut hole-and if a customer is lost to the donut hole, they may be lost for good.